Kyolic's 108 Garlic Homocysteine 100 caps: TNT Nutrition Center

Contains Aged Garlic Extract™ [250 mg], Vitamin B6 [12.5mg], Vitamin B12 [100mcg], Folic acid [200mcg], L-Arginine [100mg] (per capsule)

Studies suggest that Aged Garlic
Extract and its constituents may provide nutritional support for healthy cardiovascular function, including homocysteine, cholesterol, blood pressure, and stimulating circulation, all while inhibiting oxidative damage in the body.^1-20

Kyolic is already patented for its ability to reduce homocysteine levels, now thought to be a major risk factor for heart disease.^27,28

In a study of 734 subjects, homocysteine levels were found to be highest in subjects with the lowest intake of folic acid, vitamin B12 and vitamin B6^22.

L-Arginine, has been reported to reduce blood homocysteine levels as well as decrease blood pressure since it plays a role in increasing the availability of nitric oxide, an important vasodilator in humans.^23-²⁶

Vitamin B6 and B12, Folic Acid and L-Arginine are added since their synergy is found more effective than any one ingredient alone in facilitating the proper function of homocysteine recycling (detoxification)

Kyolic Formula 108

SUGGESTED USE:
Take two capsules with a meal twice daily.

OTHER INGREDIENTS:
Gelatin, Cellulose, Magnesium Stearate (vegetable source) and Silica.

Free of: gluten, preservatives, sugar, sodium, milk, yeast, artificial colors and flavors.

REFERENCES FOR KYOLIC Formula 108

1. Yeh, Y. Y. et al. 1994. Lipids 29(3): 189-193.
2. Yeh, Y. Y. et al. 1990. First World Congress on the Health Significance of Garlic and Garlic Constituents. Nutrition International Co., Irvine, CA., p. 37.
3. Kawashima, Y. et al. 1989. Shinryo To Shinyaku (Treat. New Med.) 26: 377-388.
4. Lau, B. et al. 1987. Nutr. Res. 7: 139-149.
5. Steiner, M. et al. 1994. J. Am. Coll. Nutr. 13(5): 524.
6. Yeh, Y. et al. 1995. J. Am. Coll. Nutr. 14(5):545.
7. Abuirmeileh, N. et al. 1991. FASEB J. 5(6): 8048.
8. Qureshi, N. et al. 1990. First World Congress on the Health Significance of Garlic and Garlic Constituents. Nutrition International Co., Irvine, CA, p. 17.
9. Qureshi, A. et al. 1990. First World Congress on the Health Significance of Garlic and Garlic Constituents. Nutrition International Co., Irvine, CA, p. 16.
10. Yeh, Y.Y. 1996. Shinyaku To Rinsho (New Drug Clin.) 45(3): 441-450.
11. Efendy, J.L.et al.1996. In: Proceedings of the 1996 Conference of the Anatomical Society of Australia and New Zealand. The Department of Anatomical Sciences, the University of Queensland. Brisbane, Australia, p. 19.
12. Efendy, J.L. et al. 1996. J. Vasc. Res. 33(S1): 23.
13. Steiner, M. et al.1996. 2nd International Congress on Phytomedicine. September 11-14, 1996. Munich, Germany.
14. Kawashima, Y. et al. 1989. Shinryou to shinyaku (Treat. New Med.) 26: 377-388.
15. Okuhara, T. 1994. Jpn. Pharmacol. Therapeut. 22(8): 3695-3701.
16. Kikuchi, T. et al. 1994. Shinyaku To Rinsho (Jpn. J. New Remedies Clin.) 43(1): 146-158.
17. Kawashima, Y. et al. Shinryou to shinyaku (Treat. New Med.) 26: 377-388, 1989.
18. Okuhara, T. 1994. Jpn. Pharmacol. Therapeut. 22(8): 3695-3701.
19. Kikuchi, T. et al. Shinyaku To Rinsho (Jpn. J. New Remedies Clin.) 43(1): 146-158, 1994.
20. Steiner, M. et al. Am. J. Clin. Nutr. 64: 866-870, 1996.
21. McCully, K. JAMA, 279(5): 392-395. 1998
22. Darlery K, et al. Am. J. Cardiol. 75(16): 1107-1111. 1995
23. Huynh, N.T., and Tayek, J.A. 2002. J Am Coll Nutr. 21(5): 422-7.
24. Cassone Faldetta,M., et al. 2002. Diabetologia. 45(8): 1120-7.
25. West, S.G., et al. 2005. J Nutr. 135(2): 212-7.
26. Kawano, H., et al. 2002. Atherosclerosis. 161(2): 375-80.
27. Yeh, Y., et al. 1999 FASEB 13(4): a232; #209.12
28. Amagase, H. 2000. Method and pharmaceutical composition for reducing serum homocysteine concentrations. Patent # 6,129,918.